Skip to content
HowShorted

How shorted is Monte Rosa Therapeutics, Inc.? GLUE

#77most shorted US stockof 3,805 ranked stocks, more shorted than 97%

22.58%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
+1.39
5 reports (~10 weeks)
−0.71
days to cover
17.08
Aggregate net short position time series for Monte Rosa Therapeutics, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Monte Rosa Therapeutics, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
6 Aug 202619.29% 31 Jul 202620.46% 14 Aug 2026+1.17
7 May 202618.92% 30 Apr 202618.70% 15 May 2026−0.22
17 Mar 202613.70% 13 Mar 202616.75% 31 Mar 2026+3.05
6 Nov 202512.27% 31 Oct 202511.36% 14 Nov 2025−0.91
7 Aug 202514.15% 31 Jul 202513.47% 15 Aug 2025−0.68
8 May 202512.81% 30 Apr 202513.65% 15 May 2025+0.84
20 Mar 202511.46% 14 Mar 20258.80% 31 Mar 2025−2.66
10 Jan 202514.90% 31 Dec 202414.27% 15 Jan 2025−0.63

Fails to deliver

The SEC's fails-to-deliver figure for GLUE: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
1,482
2 Sep 2026
Highest in window
408,788
3 Aug 2026
Days with a balance
74
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Monte Rosa Therapeutics, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 409K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare · By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 202622.58%+1.39
31 Aug 202621.19%+0.73
14 Aug 202620.46%+1.17
31 Jul 202619.29%−2.20
15 Jul 202621.49%−1.80
30 Jun 202623.29%+1.83
15 Jun 202621.46%+1.46
29 May 202620.00%+1.30
15 May 202618.70%−0.22
30 Apr 202618.92%−0.87
15 Apr 202619.79%+3.04
31 Mar 202616.75%+3.05
13 Mar 202613.70%−1.83
27 Feb 202615.53%+1.20
13 Feb 202614.33%+2.56
30 Jan 202611.77%+3.24
15 Jan 20268.53%−4.45
31 Dec 202512.98%+2.23
15 Dec 202510.75%−0.01
28 Nov 202510.76%−0.60
14 Nov 202511.36%−0.91
31 Oct 202512.27%−0.82
15 Oct 202513.09%+0.41
30 Sep 202512.68%−0.66
15 Sep 202513.34%0.00
29 Aug 202513.34%−0.13
15 Aug 202513.47%−0.68
31 Jul 202514.15%−0.35
15 Jul 202514.50%+0.09
30 Jun 202514.41%−0.01
13 Jun 202514.42%+1.29
30 May 202513.13%−0.52
15 May 202513.65%+0.84
30 Apr 202512.81%+0.56
15 Apr 202512.25%+3.45
31 Mar 20258.80%−2.66
14 Mar 202511.46%−1.64
28 Feb 202513.10%+0.02
14 Feb 202513.08%−0.08
31 Jan 202513.16%−1.11
15 Jan 202514.27%−0.63
31 Dec 202414.90%+1.21
13 Dec 202413.69%−4.32
29 Nov 202418.01%−0.16
15 Nov 202418.17%+5.40
31 Oct 202412.77%+4.25
15 Oct 20248.52%+1.39
30 Sep 20247.13%+1.80
13 Sep 20245.33%+0.34
30 Aug 20244.99%+0.44
15 Aug 20244.55%−0.99
31 Jul 20245.54%−0.17
15 Jul 20245.71%+0.61
28 Jun 20245.10%+1.15
14 Jun 20243.95%+0.15
31 May 20243.80%−0.81
15 May 20244.61%+0.79
30 Apr 20243.82%+0.10
15 Apr 20243.72%+0.36
28 Mar 20243.36%−0.28
15 Mar 20243.64%−0.04
29 Feb 20243.68%−0.27
15 Feb 20243.95%+0.13
31 Jan 20243.82%−0.10
12 Jan 20243.92%−0.19
29 Dec 20234.11%−0.60
15 Dec 20234.71%−1.22
30 Nov 20235.93%−0.17
15 Nov 20236.10%−0.68
31 Oct 20236.78%−0.78
13 Oct 20237.56%−0.55
29 Sep 20238.11%+0.36
15 Sep 20237.75%+0.55
31 Aug 20237.20%+0.90
15 Aug 20236.30%+0.64
31 Jul 20235.66%+0.32
14 Jul 20235.34%+0.11
30 Jun 20235.23%+0.28
15 Jun 20234.95%+0.30
31 May 20234.65%+0.01
15 May 20234.64%+0.10
28 Apr 20234.54%−0.51
14 Apr 20235.05%+0.15
31 Mar 20234.90%+0.41
15 Mar 20234.49%−0.24
28 Feb 20234.73%−0.42
15 Feb 20235.15%−2.56
31 Jan 20237.71%−0.06
13 Jan 20237.77%−1.20
30 Dec 20228.97%+0.13
15 Dec 20228.84%−0.17
30 Nov 20229.01%−0.64
15 Nov 20229.65%−0.79
31 Oct 202210.44%+0.11
14 Oct 202210.33%−0.68
30 Sep 202211.01%+0.49
15 Sep 202210.52%−0.38
31 Aug 202210.90%+0.68
15 Aug 202210.22%+0.32
29 Jul 20229.90%−0.01
15 Jul 20229.91%−0.07
30 Jun 20229.98%−0.60
15 Jun 202210.58%−1.68
31 May 202212.26%+0.14
13 May 202212.12%−0.03
29 Apr 202212.15%−0.22
14 Apr 202212.37%−0.43
31 Mar 202212.80%+1.21
15 Mar 202211.59%+0.85
28 Feb 202210.74%+1.06
15 Feb 20229.68%+2.35
31 Jan 20227.33%−0.23
14 Jan 20227.56%+0.38
31 Dec 20217.18%+0.23
15 Dec 20216.95%+1.02
30 Nov 20215.93%+0.49
15 Nov 20215.44%−0.05
29 Oct 20215.49%+0.32
15 Oct 20215.17%−0.28
30 Sep 20215.45%+1.27
15 Sep 20214.18%+0.46
31 Aug 20213.72%+1.16
13 Aug 20212.56%–

Newest first. Scroll inside the table for earlier dates, back to 13 Aug 2021.

Frequently asked questions

How shorted is Monte Rosa Therapeutics, Inc. right now?
22.58% of Monte Rosa Therapeutics, Inc.'s (GLUE) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 77th most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this GLUE's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is GLUE's days to cover?
17.08 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.